139 related articles for article (PubMed ID: 38164733)
1. Commentary on "Hyperbaric Oxygen Therapy Improves Neurocognitive Functions and Symptoms of Post-COVID Condition: Randomized Controlled Trial".
Leão Batista Simões J; de Carvalho Braga G; Dulce Bagatini M
Curr Pharm Des; 2023; 29(34):2679-2683. PubMed ID: 38164733
[No Abstract] [Full Text] [Related]
2. Hyperbaric Oxygen Improves Neurocognitive Function and Symptoms of Post-COVID Condition.
Rosenberg K
Am J Nurs; 2022 Nov; 122(11):61-62. PubMed ID: 36261911
[TBL] [Abstract][Full Text] [Related]
3. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: randomized controlled trial.
Zilberman-Itskovich S; Catalogna M; Sasson E; Elman-Shina K; Hadanny A; Lang E; Finci S; Polak N; Fishlev G; Korin C; Shorer R; Parag Y; Sova M; Efrati S
Sci Rep; 2022 Jul; 12(1):11252. PubMed ID: 35821512
[TBL] [Abstract][Full Text] [Related]
4. The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: a randomized controlled trial.
Leitman M; Fuchs S; Tyomkin V; Hadanny A; Zilberman-Itskovich S; Efrati S
Sci Rep; 2023 Jun; 13(1):9473. PubMed ID: 37301934
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperbaric oxygen therapy on functional and structural connectivity in post-COVID-19 condition patients: A randomized, sham-controlled trial.
Catalogna M; Sasson E; Hadanny A; Parag Y; Zilberman-Itskovich S; Efrati S
Neuroimage Clin; 2022; 36():103218. PubMed ID: 36208548
[TBL] [Abstract][Full Text] [Related]
6. Hyperbaric oxygen treatment for long coronavirus disease-19: a case report.
Bhaiyat AM; Sasson E; Wang Z; Khairy S; Ginzarly M; Qureshi U; Fikree M; Efrati S
J Med Case Rep; 2022 Feb; 16(1):80. PubMed ID: 35168680
[TBL] [Abstract][Full Text] [Related]
7. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial.
Kjellberg A; Abdel-Halim L; Hassler A; El Gharbi S; Al-Ezerjawi S; Boström E; Sundberg CJ; Pernow J; Medson K; Kowalski JH; Rodriguez-Wallberg KA; Zheng X; Catrina S; Runold M; Ståhlberg M; Bruchfeld J; Nygren-Bonnier M; Lindholm P
BMJ Open; 2022 Nov; 12(11):e061870. PubMed ID: 36323462
[TBL] [Abstract][Full Text] [Related]
8. Hyperbaric oxygen therapy in long-COVID-19 disease.
García Estévez DA; López Pérez Á; Gómez Márquez H
Med Clin (Barc); 2023 Dec; 161(11):498-499. PubMed ID: 37775412
[No Abstract] [Full Text] [Related]
9. Hyperbaric oxygen therapy for the treatment of long COVID.
Wilmshurst P; Bewley S; Murray P
Clin Med (Lond); 2023 Jan; 23(1):99-100. PubMed ID: 36697009
[No Abstract] [Full Text] [Related]
10. Hyperbaric oxygen therapy to treat lingering COVID-19 symptoms.
Zant AE; Figueroa XA; Paulson CP; Wright JK
Undersea Hyperb Med; 2022; 49(3):333-339. PubMed ID: 36001566
[TBL] [Abstract][Full Text] [Related]
11. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial.
Kjellberg A; Hassler A; Boström E; El Gharbi S; Al-Ezerjawi S; Kowalski J; Rodriguez-Wallberg KA; Bruchfeld J; Ståhlberg M; Nygren-Bonnier M; Runold M; Lindholm P
BMC Infect Dis; 2023 Jan; 23(1):33. PubMed ID: 36670365
[TBL] [Abstract][Full Text] [Related]
12. Long term outcomes of hyperbaric oxygen therapy in post covid condition: longitudinal follow-up of a randomized controlled trial.
Hadanny A; Zilberman-Itskovich S; Catalogna M; Elman-Shina K; Lang E; Finci S; Polak N; Shorer R; Parag Y; Efrati S
Sci Rep; 2024 Feb; 14(1):3604. PubMed ID: 38360929
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of hyperbaric oxygen therapy in the management of COVID-19-associated mucormycosis.
Pandey S; Kumar V; Kumar R; Mishra B; Singh A; Reddy G
Med Gas Res; 2024; 14(2):87-88. PubMed ID: 37929513
[No Abstract] [Full Text] [Related]
14. Hyperbaric Oxygen Treatment for Long COVID: From Molecular Mechanism to Clinical Practice.
Pan JQ; Tian ZM; Xue LB
Curr Med Sci; 2023 Dec; 43(6):1061-1065. PubMed ID: 37924387
[TBL] [Abstract][Full Text] [Related]
15. The effects of hyperbaric oxygen therapy (HBOT) on coronavirus disease-2019 (COVID-19): a systematic review.
Oliaei S; SeyedAlinaghi S; Mehrtak M; Karimi A; Noori T; Mirzapour P; Shojaei A; MohsseniPour M; Mirghaderi SP; Alilou S; Shobeiri P; Azadi Cheshmekabodi H; Mehraeen E; Dadras O
Eur J Med Res; 2021 Aug; 26(1):96. PubMed ID: 34412709
[TBL] [Abstract][Full Text] [Related]
16. The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review.
Paganini M; Bosco G; Perozzo FAG; Kohlscheen E; Sonda R; Bassetto F; Garetto G; Camporesi EM; Thom SR
Adv Exp Med Biol; 2021; 1289():27-35. PubMed ID: 32696443
[TBL] [Abstract][Full Text] [Related]
17. Hyperbaric oxygen therapy for treatment of COVID-19-related parosmia: a case report.
Krimus L; Hasan Rizvi S; Marinov A; Clarke H; Katznelson R
Undersea Hyperb Med; 2023; 50(4):433-435. PubMed ID: 38055885
[TBL] [Abstract][Full Text] [Related]
18. The National Brain Injury Rescue and Rehabilitation Study - a multicenter observational study of hyperbaric oxygen for mild traumatic brain injury with post-concussive symptoms.
Mozayeni BR; Duncan W; Zant E; Love TL; Beckman RL; Stoller KP
Med Gas Res; 2019; 9(1):1-12. PubMed ID: 30950414
[TBL] [Abstract][Full Text] [Related]
19. Hyperbaric oxygen therapy as a supportive therapy for COVID-19 patients: a narrative review.
Allam NM; Eladl HM; Eid MM
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5618-5623. PubMed ID: 35993661
[TBL] [Abstract][Full Text] [Related]
20. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: treated cases versus propensity-matched controls.
Gorenstein SA; Castellano ML; Slone ES; Gillette B; Liu H; Alsamarraie C; Jacobson AM; Wall SP; Adhikari S; Swartz JL; McMullen JJS; Osorio M; Koziatek CA; Lee DC
Undersea Hyperb Med; 2020; 47(3):405-413. PubMed ID: 32931666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
